Recent Categories
Recent Posts
- Reform or Continuity: RD Bansal v. Harper Collins and the Limits of Protecting Screenplay Writers’ Copyright
- The pen maker or the writer-who gets the copyright in the world of artificial intelligence?
- Mandatory Stay of Civil Suits Under Section 124 of the Trademarks Act: Navigating Post-IPAB Jurisprudence
- McDonald’s Smell the IP Protection?
- Blurred Lines on the Silver Screen: Redefining Legal Boundaries for Biopics.
Post Archive
- December 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- April 2023
- March 2023
- February 2023
- January 2023
- November 2022
- September 2022
- May 2022
- April 2022
- January 2022
- December 2021
- October 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- September 2019
Catogery Tags
11th Hour Injunction AI Artificial Intelligence Artistic Work Bioethical Issues Blockchain CBDC censorship Centralized Digital Currency Covid-19 Cryptocurrency Data Privacy DeFi Dispute Resolution DU Photocopy Case encryption Fair Use Freedom of Expression Gaming Law goodwill high value datasets Informed Consent Infringement Copy Injunction internet censorship Internet Memes IPR Disputes IT Act Memes NFT Non-Fungible Tokens Non-obviousness Test non-personal data NPD Online Gaming Patents Patents Act Quia Timet Sci-Hub Smart Contracts standard essential patents Technology transborder trademarks Well-known Trademarks White Tiger Case
Connect With Us
-
Exit Strategies For 11th Hour Copyright Lawsuits in Light of Covid-19
The authors discuss the concept of Last-Minute injunctions and analyse cases, in India and abroad, concerning such injunctions.
-
Patenting Issues for Covid-19 Antibodies in India
[This post has been authored by Debaditya Duttagupta, a student at the National Law University, Odisha.] Introduction There are more than 100 COVID-19 treatments in various stages of trials, approval and rollout across the world with antibody treatments are becoming one of the most popular drugs. Accordingly, one of the top-selling drugs of 2019 was…
-
The Need for a Pandemic Patent Tool: Sine Qua Non Amidst the Havoc?
[This article has been authored by Ashika Jain and Lakshay Garg, students at Gujarat National Law University.] Background Amid the COVID-19 Pandemic, all nations are endeavouring to find a vaccine for the virus. The quest for creating the vaccine has kick-started a race, leading countries/organizations/medical firms into finding a cure before the pandemic wrecks further…
